Docking analysis of gallic acid derivatives as HIV-1 protease inhibitors

HIV-1 Protease (HIV-1 PR) enzymes are essential for accurate assembly and maturation of infectious HIV retroviruses. The significant role of HIV-1 protease in viral replication has made it a potential drug target. In the recent past, phytochemical Gallic Acid (GA) derivatives have been screened for...

Full description

Saved in:
Bibliographic Details
Published in:International journal of bioinformatics research and applications Vol. 11; no. 6; p. 540
Main Authors: Singh, Anjali, Pal, Tapan Kumar
Format: Journal Article
Language:English
Published: Switzerland 2015
Subjects:
viral replication
phytoinhibitors
amprenavir
HIV retroviruses
anti-HIV drugs
bioinformatics
drug targets
darunavir
gallic acid derivatives
HIV-1 protease inhibitors
docking analysis
ISSN:1744-5485
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:HIV-1 Protease (HIV-1 PR) enzymes are essential for accurate assembly and maturation of infectious HIV retroviruses. The significant role of HIV-1 protease in viral replication has made it a potential drug target. In the recent past, phytochemical Gallic Acid (GA) derivatives have been screened for protease inhibitor activity. The present work aims to design and evaluate potential GA-based HIV-1 PR phytoinhibitors by docking approach. The ligands were prepared by ChemDraw and docking was performed in HEX software. In this present study, one of the GA analogues (GA4) emerged as a potent drug candidate for HIV-1 PR inhibition, and docking results showed it to be comparable with anti-HIV drugs, darunavir and amprenavir. The GA4 derivative provided a lead for designing more effective HIV-1 PR inhibitors.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1744-5485
DOI:10.1504/IJBRA.2015.073239